Issue - meetings

To consider a report of the Director of Public Health.

The report provides an update on progress for the Joint Strategic Needs Assessment (JSNA) and Pharmaceutical Needs Assessment (PNA) programmes for 2014/15. The Board previously considered an update in November 2013, and since then the proposals endorsed by the Board have been implemented and planning for the 2014/15 work programmes has been completed by the JSNA project leads group and the PNA project group. The report summarises these plans and seeks to provide an opportunity to discuss the proposals and to receive assurance that the work planned will meet the Board’s objectives.

The Board is invited to:-

·      endorse the recommendation to publish the supplementary statement to the Pharmaceutical Needs Assessment (PNA) and for the purposes of the PNA to treat Stockport as a single locality;

·      approve the recommendation to present analysis for the JSNA at the CCG locality and priority area level wherever appropriate;

·      discuss the work plans for the JSNA and comment on and approve the proposed data collection and products.

Officer contact: Eleanor Banister, Tel: 0161 474 2447, eleanor.banister@stockport.gov.uk

A representative of the Deputy Director of Public Health submitted a report (copies of which had been circulated) providing an update to the Board on the development of the Joint Strategic Needs Assessment (JSNA) and the Pharmaceutical Needs Assessment (PNA) for 2014/15, including summaries of the project plans for both Assessments.

Members welcomed the progress being made.

The following comments were made/ issues:

·         The last JSNA was subject to extensive public consultation which was a strength of the process. Consideration should be given to including information in the Council’s Review.

·         Consideration should be given to including data around accommodation and looked after children placed in Stockport by other local authorities. It may also be beneficial to consider issues to have arisen from the various transformation projects to determine emerging needs.

·         The role of HealthWatch in the JSNA was welcomed and pointed to the strength of process.

RESOLVED – (1) That the report be noted.

(2) That the proposal to publish the supplementary statement to the Pharmaceutical Needs Assessment and to treat Stockport as a single locality for the purpose of the Assessment be endorsed.

(3) That the proposal to present analysis for the JSNA at the Clinical Commissioning Group locality and priority area level wherever appropriate be approved.

(4) That the Director of Public Health be requested to submit a report to the September board meeting detailing the proposed Pharmaceutical Needs Assessment consultation.